The company's development will be presented by Elekta's President and CEO, Richard Hausmann, together with CFO, Gustaf Salford. The presentation will be held in English at Elekta's headquarters in Stockholm.
The presentation will also be broadcast live online and via phone conference. It will be necessary to join the phone conference (https://elekta-qreports.creo.se/190822) if you plan to ask questions. A recording of the
webcast can be found on Elekta's website after the event.
Welcome!
Time:
Thursday, August 22, at 10:00 am CET
Venue live event:
Elekta HQ, Kungstensgatan 18, Stockholm, 8th floor
Telephone numbers to join phone conference:
UK: +44 33 330 092 73
US: +1 833 5268 347
SE: +46 8 505 583 65
Web address to join:
https://elekta-qreports.creo.se/190822 (https://elekta-qreports.creo.se/190822/elekta_q1_presentation_and_conference_call)
# # #
For further information, please contact:
Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25, e-mail: cecilia.ketels@elekta.com
Time zone: CET: Central European Time
About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com (http://www.elekta.com) or follow @Elektaon Twitter.